The post-COVID-19 conditions (PCC) or long COVID prevalence among United States (US) adults infected with SARS-CoV-2.
By Pooja Toshniwal PahariaReviewed by Lily Ramsey, LLMJul 25 2024 In a recent study published in the Annals of Family Medicine , researchers estimated the post-coronavirus disease 2019 conditions or long COVID prevalence among United States adults infected with severe acute respiratory syndrome coronavirus 2 .
Existing research on PCC symptoms is expanding; however, there are constraints, especially concerning healthcare delivery in the US. Issues include low generalizability owing to patient identification criteria, a lack of variety in patient features, inadequate follow-up time, and unpredictability in outcome measurements.
Eligible participants visited primary care practices at least once in 12 or more months before COVID-19 and one or more visits two weeks to one year before diagnosis, excluding those who turned inactive within three months of their diagnosis. The team identified contemporaneous controls for 2020 and 2021 using current procedural terminology codes.
However, the team found no differences in the postdiagnosis monthly trend in cumulative morbidity between ILI and COVID-19 patients. Relative to contemporaneous wellness controls, COVID-19 patients had higher prevalence rates for type 2 diabetes and breathing difficulties.
Breathing Chronic Coronavirus Covid-19 Diabetes Diabetes Mellitus Diagnostic Healthcare Hospital Influenza Medicine Research Respiratory SARS SARS-Cov-2 Severe Acute Respiratory Severe Acute Respiratory Syndrome Sleep Syndrome Type 2 Diabetes
United Kingdom Latest News, United Kingdom Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
New study highlights impact of sleep disturbances on COVID-19 and long COVIDThe influence of pre-existing sleep disturbances on coronavirus disease 2019 (COVID-19) susceptibility, severity, and long-term effects.
Read more »
Nearly 1 in 10 pregnant people who get COVID will develop long COVID, study findsNearly 1 in 10 people who get COVID while pregnant will go on to develop long COVID, a report in Obstetrics & Gynecology has found.
Read more »
New study links COVID-19 to lasting neuropsychiatric issues, highlights vaccination benefitsCOVID-19 survivors face significantly higher risks of developing neuropsychiatric conditions, but vaccination reduces these risks over time.
Read more »
Text reminders about COVID-19 boosters are as effective as free rides, new study findsIn the first 10 months of availability, COVID-19 vaccines prevented around 235,000 deaths and 1.6 million hospitalizations in the U.S. However, by April 2023, 19% of Americans still hadn't received their first vaccine dose and 65% hadn't completed all recommended boosters, leading to tens of thousands of preventable deaths.
Read more »
Common respiratory infections may have protected children from COVID-19, study suggestsAnalyzing nasal swabs taken during the pandemic, researchers at Yale School of Medicine suggest that the frequent presence of other viruses and bacteria may have helped to protect children from the worst effects of COVID-19 by boosting their immune systems. Their results are published July 1 in the Journal of Experimental Medicine (JEM).
Read more »
Study links common infections to enhanced COVID-19 defense in childrenAnalyzing nasal swabs taken during the pandemic, researchers at Yale School of Medicine suggest that the frequent presence of other viruses and bacteria may have helped to protect children from the worst effects of COVID-19 by boosting their immune systems.
Read more »